Monitoring and integration of the initiative on an international scale, in the field of genomic medicine
As part of the international competition underway, it is necessary to follow developments in the field of genomic medicine on an international scale, in order to be able to anticipate the necessary adaptations and reorientations, as part of the implementation of the plan and guarantee optimal quality of service to patients, while preserving the competitiveness of national players in the developed industrial sector.
Where are we ?
Aviesan, the National Alliance for Life and Health Sciences (represented by INSERM) and the Danish National Genomics Center (DNGC) signed a collaboration agreement (Memorandum of Understanding – MoU) on March 6 in the French Embassy in Copenhagen.
As both the French and Danish initiatives aim to implement genomic medicine into the patient care pathway, they face very similar challenges. The signing of this memorandum of understanding will make it possible to share experiences and develop common approaches, in order to move forward more quickly in different areas.